United States Sperm Bank - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The united states sperm bank market size is projected to be USD 1.84 billion in 2025, USD 1.9 billion in 2026, and reach USD 2.26 billion by 2031, growing at a CAGR of 3.52% from 2026 to 2031. This report is Segmented by Service (Donor Sperm Banking and Distribution, Client Sperm Banking and Long-Term Storage, Semen Analysis and Male Fertility Testing, and More), Donor Type (Known Donor, Anonymous Donor, Identity-Release Donor), and End User (Fertility Clinics and IVF Centers, Hospitals and Academic Reproductive Centers, and More). The Market Forecasts are Provided in Terms of Value (USD).

United States Sperm Bank Market Trends and Insights

Delayed Parenthood and Male Fertility Decline

Later parenthood is widening the gap between the years when many men are building careers and the years when fertility is strongest, and that timing mismatch is supporting earlier preservation decisions across the US sperm bank market. This change is moving sperm banking beyond medically diagnosed infertility and into preventive use by men who want to preserve options before cancer care, military deployment, aging, or a delayed family-building decision. That matters financially because samples that enter storage earlier can stay active for years, which extends billing duration and makes long-term storage revenue less tied to immediate treatment cycles. The US sperm bank market also benefits from wider awareness that semen quality does not stay constant and can deteriorate before a fertility issue is formally diagnosed. A peer-reviewed article in Cell Death Discovery reported a continuing annual decline in sperm concentration, reinforcing the case for earlier preservation and more frequent testing among men who still see themselves as healthy. This leaves the US sperm bank market with a firmer recurring revenue base than one built only on donor vials for near-term conception.

LGBTQ+ and Single-Woman Family Building

The user mix in the US sperm bank market has moved decisively toward single women and LGBTQ+ households, and this change is now central to how demand is formed. A 2026 Boston University Law Review analysis found that unpartnered women and LGBTQ+ people together account for nearly 75% of those using donor sperm in assisted reproduction. NPR reported in January 2026 that more single women in their 40s are using IVF to have children, which keeps donor sperm demand active outside the older treatment pattern centered on heterosexual couples with infertility. Marketplace reported in 2025 that clinics were seeing continued growth in inquiries from single women planning parenthood on their own timeline, which supports a steady intake pipeline for the US sperm bank market. These clients often approach treatment as a deliberate family-building decision, which can make demand more stable even when care is paid out of pocket. The US sperm bank market also benefits because many recipients want formal screening, traceable records, and clear legal documentation that licensed cryobanks can offer more consistently than informal arrangements.

High Out-of-Pocket Donor Sperm and Storage Costs

Cost remains the clearest barrier for people who must pay directly for donor sperm, storage, and related fertility treatment without employer support or state-level benefit help. This pressure is strongest outside large employer plans and outside states where fertility coverage is already more established, which keeps parts of the US sperm bank market reliant on self-funded demand. The problem is especially visible in direct-to-consumer preservation, where the service is easier to access but reimbursement is still uneven and often absent. Microsoft, Yale University, and Baylor University now cover sperm freezing through benefit arrangements, but those examples also show how selective current access remains rather than how universal it has become. The proposed federal fertility benefit rule may improve access over time, but it has not yet removed the heavy out-of-pocket burden many families still face in 2026. Until coverage broadens materially, price will keep limiting conversion in the US sperm bank market, especially in services that depend on planned but discretionary family-building decisions.

Other drivers and restraints analyzed in the detailed report include:

• Employer-Funded Fertility Benefits Expansion
• Expanded Carrier Screening and Donor-Matching Tools
• Stringent Donor Screening Constraining Supply

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Donor Sperm Banking and Distribution held 38.31% of the US sperm bank market share in 2025, making it the main volume center within the US sperm bank market. Every donor conception cycle passes through this layer, so it benefits from both clinic referrals and direct buyer demand even when the end use varies. That volume base is reinforced by the way clinics depend on stable donor catalogs, reliable shipping, and repeat purchases across insemination and IVF cycles. Client Sperm Banking and Long-Term Storage adds a separate demand stream, because healthy men, cancer patients, and employer-sponsored users are preserving samples earlier than before. Semen Analysis and Male Fertility Testing also supports activity, but part of this work is moving outside clinic walls as home-based collection and mail-in testing become more accepted across the US sperm bank market.

Genetic Counseling and Donor Matching Support is projected to grow at a 6.38% CAGR through 2031, the fastest service rate within the US sperm bank market size by service. This service is gaining value because expanded carrier screening, phenotype review, and disclosure questions are harder for intended parents to navigate without professional support. A 2025 study in the Journal of Assisted Reproduction and Genetics reported that Cryos International shifted from the term anonymous to non-ID release, reflecting how genetic databases are reshaping expectations around donor identity. That language change increases the need for counseling during donor choice, because recipients now weigh future identity access more directly than they did in earlier years. Directed Donor Screening and Quarantine remains smaller and slower to scale, but it keeps a durable role because regulated handling and release rules are difficult to bypass in the US sperm bank industry.

Complete Report Scope:

• By Service
  • Donor Sperm Banking and Distribution
  • Client Sperm Banking and Long-Term Storage
  • Semen Analysis and Male Fertility Testing
  • Directed Donor Screening and Quarantine
  • Genetic Counseling and Donor Matching Support
• By Donor Type
  • Known Donor
  • Anonymous Donor
  • Identity-Release Donor
• By End User
  • Fertility Clinics and IVF Centers
  • Hospitals and Academic Reproductive Centers
  • Direct-to-Consumer Fertility Preservation Clients

List of Companies Covered in this Report:

• California Cryobank
• Cascade Cryobank
• Cryobank America
• CryoGam Colorado
• Cryos International USA
• Denver Sperm Bank
• Fairfax Cryobank
• Legacy
• Maze Laboratories
• Midwest Sperm Bank
• New England Cryogenic Center
• ReproTech LLC
• Seattle Sperm Bank
• The Sperm Bank of California
• The World Egg and Sperm Bank
• Xytex

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support